speb/financial-data huggingface dataset:
CLSK income_statement (quarterly, 2025-09-30) — Gain On Sale Of Ppe: -2529000.00
CLSK income_statement (annual, 2025-09-30) — Gain On Sale Of Security: -1546000.00
CLSK income_statement (quarterly, 2025-09-30) — Gain On Sale Of Security: 3000.00
CLSK balance_sheet (annual, 2025-09-30) — Gains Losses Not Affecting Retained Earnings: 0.00
CLSK balance_sheet (quarterly, 2025-09-30) — Gains Losses Not Affecting Retained Earnings: 0.00
CLSK income_statement (annual, 2025-09-30) — General And Administrative Expense: 66410000.00
CLSK income_statement (quarterly, 2025-09-30) — General And Administrative Expense: 18182000.00
CLSK balance_sheet (annual, 2025-09-30) — Goodwill: 131658000.00
CLSK balance_sheet (quarterly, 2025-09-30) — Goodwill: 131658000.00
CLSK balance_sheet (annual, 2025-09-30) — Goodwill And Other Intangible Assets: 137507000.00
CLSK balance_sheet (quarterly, 2025-09-30) — Goodwill And Other Intangible Assets: 137507000.00
CLSK balance_sheet (annual, 2025-09-30) — Gross PPE: 2039915000.00
CLSK balance_sheet (quarterly, 2025-09-30) — Gross PPE: 2039915000.00
CLSK income_statement (annual, 2025-09-30) — Gross Profit: 318834000.00
CLSK income_statement (quarterly, 2025-09-30) — Gross Profit: 74536000.00
CLSK balance_sheet (annual, 2025-09-30) — Hedging Assets Current: 233000.00
CLSK balance_sheet (quarterly, 2025-09-30) — Hedging Assets Current: 233000.00
CLSK income_statement (annual, 2025-09-30) — Impairment Of Capital Assets: 0.00
CLSK income_statement (quarterly, 2025-09-30) — Impairment Of Capital Assets: 0.00
CLSK income_statement (annual, 2025-09-30) — Interest Expense: 11335000.00
CLSK income_statement (quarterly, 2025-09-30) — Interest Expense: 5055000.00
CLSK income_statement (annual, 2025-09-30) — Interest Expense Non Operating: 11335000.00
CLSK income_statement (quarterly, 2025-09-30) — Interest Expense Non Operating: 5055000.00
CLSK income_statement (annual, 2025-09-30) — Interest Income: 4125000.00
CLSK income_statement (quarterly, 2025-09-30) — Interest Income: 280000.00
CLSK income_statement (annual, 2025-09-30) — Interest Income Non Operating: 4125000.00
CLSK income_statement (quarterly, 2025-09-30) — Interest Income Non Operating: 280000.00
CLSK cash_flow (annual, 2025-09-30) — Interest Paid Supplemental Data: 8879000.00
CLSK cash_flow (quarterly, 2025-09-30) — Interest Paid Supplemental Data: 4304000.00
CLSK balance_sheet (annual, 2025-09-30) — Invested Capital: 2996281000.00
CLSK balance_sheet (quarterly, 2025-09-30) — Invested Capital: 2996281000.00
CLSK cash_flow (annual, 2025-09-30) — Investing Cash Flow: -305656000.00
CLSK cash_flow (quarterly, 2025-09-30) — Investing Cash Flow: 135498000.00
CLSK balance_sheet (annual, 2025-09-30) — Investmentin Financial Assets: 222614000.00
CLSK balance_sheet (quarterly, 2025-09-30) — Investmentin Financial Assets: 222614000.00
CLSK balance_sheet (annual, 2025-09-30) — Investments And Advances: 222614000.00
CLSK balance_sheet (quarterly, 2025-09-30) — Investments And Advances: 222614000.00
CLSK cash_flow (annual, 2025-09-30) — Issuance Of Capital Stock: 186808000.00
CLSK cash_flow (quarterly, 2025-09-30) — Issuance Of Capital Stock: 0.00
CLSK cash_flow (annual, 2025-09-30) — Issuance Of Debt: 889195000.00
CLSK cash_flow (quarterly, 2025-09-30) — Issuance Of Debt: 77000000.00
CLSK balance_sheet (annual, 2025-09-30) — Land And Improvements: 49236000.00
CLSK balance_sheet (quarterly, 2025-09-30) — Land And Improvements: 49236000.00
CLSK balance_sheet (annual, 2025-09-30) — Leases: 2941000.00
CLSK balance_sheet (quarterly, 2025-09-30) — Leases: 2941000.00
CLSK balance_sheet (annual, 2025-09-30) — Long Term Capital Lease Obligation: 3281000.00
CLSK balance_sheet (quarterly, 2025-09-30) — Long Term Capital Lease Obligation: 3281000.00
CLSK balance_sheet (annual, 2025-09-30) — Long Term Debt: 644586000.00
CLSK balance_sheet (quarterly, 2025-09-30) — Long Term Debt: 644586000.00
CLSK balance_sheet (annual, 2025-09-30) — Long Term Debt And Capital Lease Obligation: 647867000.00
CLSK balance_sheet (quarterly, 2025-09-30) — Long Term Debt And Capital Lease Obligation: 647867000.00
CLSK cash_flow (annual, 2025-09-30) — Long Term Debt Issuance: 889195000.00
CLSK cash_flow (quarterly, 2025-09-30) — Long Term Debt Issuance: 77000000.00
CLSK cash_flow (annual, 2025-09-30) — Long Term Debt Payments: -136005000.00
CLSK cash_flow (quarterly, 2025-09-30) — Long Term Debt Payments: -77458000.00
CLSK balance_sheet (annual, 2025-09-30) — Machinery Furniture Equipment: 19604000.00
CLSK balance_sheet (quarterly, 2025-09-30) — Machinery Furniture Equipment: 19604000.00
CLSK cash_flow (annual, 2025-09-30) — Net Business Purchase And Sale: -6694000.00
CLSK cash_flow (quarterly, 2025-09-30) — Net Business Purchase And Sale: -34518000.00
CLSK cash_flow (annual, 2025-09-30) — Net Common Stock Issuance: 41808000.00
CLSK cash_flow (quarterly, 2025-09-30) — Net Common Stock Issuance: 0.00
CLSK balance_sheet (annual, 2025-09-30) — Net Debt: 778190000.00
CLSK balance_sheet (quarterly, 2025-09-30) — Net Debt: 778190000.00
CLSK income_statement (annual, 2025-09-30) — Net Income: 364464000.00
CLSK income_statement (quarterly, 2025-09-30) — Net Income: -925000.00
CLSK income_statement (annual, 2025-09-30) — Net Income Common Stockholders: 353324000.00
CLSK income_statement (quarterly, 2025-09-30) — Net Income Common Stockholders: -1321000.00
CLSK income_statement (annual, 2025-09-30) — Net Income Continuous Operations: 364464000.00
CLSK income_statement (quarterly, 2025-09-30) — Net Income Continuous Operations: -925000.00
CLSK income_statement (annual, 2025-09-30) — Net Income Discontinuous Operations: 0.00
CLSK income_statement (annual, 2025-09-30) — Net Income From Continuing And Discontinued Operation: 364464000.00
CLSK income_statement (quarterly, 2025-09-30) — Net Income From Continuing And Discontinued Operation: -925000.00
CLSK income_statement (annual, 2025-09-30) — Net Income From Continuing Operation Net Minority Interest: 364464000.00
CLSK income_statement (quarterly, 2025-09-30) — Net Income From Continuing Operation Net Minority Interest: -925000.00
CLSK cash_flow (annual, 2025-09-30) — Net Income From Continuing Operations: 364464000.00
CLSK cash_flow (quarterly, 2025-09-30) — Net Income From Continuing Operations: -925000.00
CLSK income_statement (annual, 2025-09-30) — Net Income Including Noncontrolling Interests: 364464000.00
CLSK income_statement (quarterly, 2025-09-30) — Net Income Including Noncontrolling Interests: -925000.00
CLSK income_statement (annual, 2025-09-30) — Net Interest Income: -7210000.00
CLSK income_statement (quarterly, 2025-09-30) — Net Interest Income: -4775000.00
CLSK cash_flow (annual, 2025-09-30) — Net Investment Purchase And Sale: 227627000.00
CLSK cash_flow (quarterly, 2025-09-30) — Net Investment Purchase And Sale: 181745000.00
CLSK cash_flow (annual, 2025-09-30) — Net Issuance Payments Of Debt: 753190000.00
CLSK cash_flow (quarterly, 2025-09-30) — Net Issuance Payments Of Debt: -458000.00
CLSK cash_flow (annual, 2025-09-30) — Net Long Term Debt Issuance: 753190000.00
CLSK cash_flow (quarterly, 2025-09-30) — Net Long Term Debt Issuance: -458000.00
CLSK income_statement (annual, 2025-09-30) — Net Non Operating Interest Income Expense: -7210000.00
CLSK income_statement (quarterly, 2025-09-30) — Net Non Operating Interest Income Expense: -4775000.00
CLSK cash_flow (annual, 2025-09-30) — Net Other Financing Charges: -96310000.00
CLSK cash_flow (quarterly, 2025-09-30) — Net Other Financing Charges: -2010000.00
CLSK cash_flow (annual, 2025-09-30) — Net Other Investing Changes: 36284000.00
CLSK cash_flow (quarterly, 2025-09-30) — Net Other Investing Changes: 418569000.00
CLSK balance_sheet (annual, 2025-09-30) — Net PPE: 1479972000.00
CLSK balance_sheet (quarterly, 2025-09-30) — Net PPE: 1479972000.00
CLSK cash_flow (annual, 2025-09-30) — Net PPE Purchase And Sale: -562873000.00
CLSK cash_flow (quarterly, 2025-09-30) — Net PPE Purchase And Sale: -430298000.00
CLSK balance_sheet (annual, 2025-09-30) — Net Tangible Assets: 2037620000.00
CLSK balance_sheet (quarterly, 2025-09-30) — Net Tangible Assets: 2037620000.00
CLSK balance_sheet (annual, 2025-09-30) — Non Current Deferred Liabilities: 44872000.00
CLSK balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Liabilities: 44872000.00
CLSK balance_sheet (annual, 2025-09-30) — Non Current Deferred Taxes Liabilities: 44872000.00
CLSK balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Taxes Liabilities: 44872000.00
CLSK income_statement (annual, 2025-09-30) — Normalized EBITDA: 764455000.00
CLSK income_statement (quarterly, 2025-09-30) — Normalized EBITDA: 129811000.00
CLSK income_statement (annual, 2025-09-30) — Normalized Income: 365556630.00
CLSK income_statement (quarterly, 2025-09-30) — Normalized Income: 1070540.00
CLSK balance_sheet (annual, 2025-09-30) — Notes Receivable: 0.00
CLSK balance_sheet (quarterly, 2025-09-30) — Notes Receivable: 0.00
CLSK cash_flow (annual, 2025-09-30) — Operating Cash Flow: -461032000.00
CLSK cash_flow (quarterly, 2025-09-30) — Operating Cash Flow: -119409000.00
CLSK cash_flow (annual, 2025-09-30) — Operating Gains Losses: -857294000.00
CLSK cash_flow (quarterly, 2025-09-30) — Operating Gains Losses: -422941000.00
CLSK income_statement (annual, 2025-09-30) — Operating Income: -107033000.00
CLSK income_statement (quarterly, 2025-09-30) — Operating Income: -63093000.00
CLSK income_statement (annual, 2025-09-30) — Operating Revenue: 766314000.00
CLSK income_statement (quarterly, 2025-09-30) — Operating Revenue: 223652000.00
CLSK balance_sheet (annual, 2025-09-30) — Ordinary Shares Number: 284327598.00
CLSK balance_sheet (quarterly, 2025-09-30) — Ordinary Shares Number: 284327598.00
CLSK balance_sheet (annual, 2025-09-30) — Other Current Assets: 11875000.00
CLSK balance_sheet (quarterly, 2025-09-30) — Other Current Assets: 11875000.00
CLSK balance_sheet (annual, 2025-09-30) — Other Current Liabilities: 6096000.00
CLSK balance_sheet (quarterly, 2025-09-30) — Other Current Liabilities: 6096000.00
CLSK income_statement (annual, 2025-09-30) — Other Gand A: 66410000.00
CLSK income_statement (quarterly, 2025-09-30) — Other Gand A: 18182000.00
CLSK income_statement (annual, 2025-09-30) — Other Income Expense: 517818000.00
CLSK income_statement (quarterly, 2025-09-30) — Other Income Expense: 81773000.00
CLSK balance_sheet (annual, 2025-09-30) — Other Intangible Assets: 5849000.00
CLSK balance_sheet (quarterly, 2025-09-30) — Other Intangible Assets: 5849000.00
CLSK cash_flow (annual, 2025-09-30) — Other Non Cash Items: 5160000.00
CLSK cash_flow (quarterly, 2025-09-30) — Other Non Cash Items: 549749000.00
CLSK balance_sheet (annual, 2025-09-30) — Other Non Current Assets: 23497000.00
CLSK balance_sheet (quarterly, 2025-09-30) — Other Non Current Assets: 23497000.00
CLSK income_statement (annual, 2025-09-30) — Other Non Operating Income Expenses: 519028000.00
CLSK income_statement (quarterly, 2025-09-30) — Other Non Operating Income Expenses: 84299000.00
CLSK balance_sheet (annual, 2025-09-30) — Other Properties: 300091000.00
CLSK balance_sheet (quarterly, 2025-09-30) — Other Properties: 300091000.00
CLSK balance_sheet (annual, 2025-09-30) — Other Receivables: 294648000.00
CLSK balance_sheet (quarterly, 2025-09-30) — Other Receivables: 294648000.00
CLSK balance_sheet (annual, 2025-09-30) — Other Short Term Investments: 966829000.00
CLSK balance_sheet (quarterly, 2025-09-30) — Other Short Term Investments: 966829000.00
CLSK income_statement (annual, 2025-09-30) — Other Taxes: 11122000.00
CLSK balance_sheet (annual, 2025-09-30) — Payables: 15555000.00
CLSK balance_sheet (quarterly, 2025-09-30) — Payables: 15555000.00
CLSK balance_sheet (annual, 2025-09-30) — Payables And Accrued Expenses: 133099000.00
CLSK balance_sheet (quarterly, 2025-09-30) — Payables And Accrued Expenses: 133099000.00
CLSK balance_sheet (annual, 2025-09-30) — Preferred Shares Number: 1750000.00
CLSK balance_sheet (quarterly, 2025-09-30) — Preferred Shares Number: 1750000.00
CLSK balance_sheet (annual, 2025-09-30) — Preferred Stock: 2000.00
CLSK balance_sheet (quarterly, 2025-09-30) — Preferred Stock: 2000.00
CLSK cash_flow (annual, 2025-09-30) — Preferred Stock Dividend Paid: -10744000.00
CLSK cash_flow (quarterly, 2025-09-30) — Preferred Stock Dividend Paid: -5603000.00
CLSK income_statement (annual, 2025-09-30) — Preferred Stock Dividends: 11140000.00
CLSK income_statement (quarterly, 2025-09-30) — Preferred Stock Dividends: 396000.00
CLSK balance_sheet (annual, 2025-09-30) — Preferred Stock Equity: 2000.00
CLSK balance_sheet (quarterly, 2025-09-30) — Preferred Stock Equity: 2000.00
CLSK income_statement (annual, 2025-09-30) — Pretax Income: 403575000.00
CLSK income_statement (quarterly, 2025-09-30) — Pretax Income: 13905000.00
CLSK cash_flow (annual, 2025-09-30) — Proceeds From Stock Option Exercised: 922000.00
CLSK cash_flow (quarterly, 2025-09-30) — Proceeds From Stock Option Exercised: 423000.00
CLSK balance_sheet (annual, 2025-09-30) — Properties: 1446818000.00
CLSK balance_sheet (quarterly, 2025-09-30) — Properties: 1446818000.00
CLSK cash_flow (annual, 2025-09-30) — Purchase Of Business: -8105000.00
CLSK cash_flow (quarterly, 2025-09-30) — Purchase Of Business: 6903000.00
CLSK cash_flow (annual, 2025-09-30) — Purchase Of Investment: -160184000.00
CLSK cash_flow (quarterly, 2025-09-30) — Purchase Of Investment: -78032000.00
CLSK cash_flow (annual, 2025-09-30) — Purchase Of PPE: -562873000.00
CLSK cash_flow (quarterly, 2025-09-30) — Purchase Of PPE: -428887000.00
CLSK balance_sheet (annual, 2025-09-30) — Receivables: 294648000.00
CLSK balance_sheet (quarterly, 2025-09-30) — Receivables: 294648000.00
CLSK income_statement (annual, 2025-09-30) — Reconciled Cost Of Revenue: 447480000.00
CLSK income_statement (quarterly, 2025-09-30) — Reconciled Cost Of Revenue: 149116000.00
CLSK income_statement (annual, 2025-09-30) — Reconciled Depreciation: 348335000.00
CLSK income_statement (quarterly, 2025-09-30) — Reconciled Depreciation: 108325000.00
CLSK cash_flow (annual, 2025-09-30) — Repayment Of Debt: -136005000.00
CLSK cash_flow (quarterly, 2025-09-30) — Repayment Of Debt: -77458000.00
CLSK cash_flow (annual, 2025-09-30) — Repurchase Of Capital Stock: -145000000.00
CLSK cash_flow (quarterly, 2025-09-30) — Repurchase Of Capital Stock: 0.00
CLSK balance_sheet (annual, 2025-09-30) — Restricted Cash: 3490000.00
CLSK balance_sheet (quarterly, 2025-09-30) — Restricted Cash: 3490000.00
CLSK income_statement (annual, 2025-09-30) — Restructuring And Mergern Acquisition: 0.00
CLSK balance_sheet (annual, 2025-09-30) — Retained Earnings: -125894000.00
CLSK balance_sheet (quarterly, 2025-09-30) — Retained Earnings: -125894000.00
CLSK cash_flow (annual, 2025-09-30) — Sale Of Business: 1411000.00
CLSK cash_flow (quarterly, 2025-09-30) — Sale Of Business: -41421000.00
CLSK cash_flow (annual, 2025-09-30) — Sale Of Investment: 387811000.00
CLSK cash_flow (quarterly, 2025-09-30) — Sale Of Investment: 259777000.00
CLSK income_statement (annual, 2025-09-30) — Selling General And Administration: 66410000.00
CLSK income_statement (quarterly, 2025-09-30) — Selling General And Administration: 18182000.00
CLSK balance_sheet (annual, 2025-09-30) — Share Issued: 296087533.00
CLSK balance_sheet (quarterly, 2025-09-30) — Share Issued: 296087533.00
CLSK income_statement (annual, 2025-09-30) — Special Income Charges: 336000.00
CLSK income_statement (quarterly, 2025-09-30) — Special Income Charges: -2529000.00
CLSK cash_flow (annual, 2025-09-30) — Stock Based Compensation: 45335000.00
CLSK cash_flow (quarterly, 2025-09-30) — Stock Based Compensation: 34726000.00
CLSK balance_sheet (annual, 2025-09-30) — Stockholders Equity: 2175127000.00
CLSK balance_sheet (quarterly, 2025-09-30) — Stockholders Equity: 2175127000.00
CLSK balance_sheet (annual, 2025-09-30) — Tangible Book Value: 2037618000.00
CLSK balance_sheet (quarterly, 2025-09-30) — Tangible Book Value: 2037618000.00
CLSK income_statement (annual, 2025-09-30) — Tax Effect Of Unusual Items: -117370.00
CLSK income_statement (quarterly, 2025-09-30) — Tax Effect Of Unusual Items: -530460.00
CLSK income_statement (annual, 2025-09-30) — Tax Provision: 39111000.00
CLSK income_statement (quarterly, 2025-09-30) — Tax Provision: 14830000.00
CLSK income_statement (annual, 2025-09-30) — Tax Rate For Calcs: 0.10
CLSK income_statement (quarterly, 2025-09-30) — Tax Rate For Calcs: 0.21
CLSK balance_sheet (annual, 2025-09-30) — Total Assets: 3183631000.00
CLSK balance_sheet (quarterly, 2025-09-30) — Total Assets: 3183631000.00
CLSK balance_sheet (annual, 2025-09-30) — Total Capitalization: 2819713000.00
CLSK balance_sheet (quarterly, 2025-09-30) — Total Capitalization: 2819713000.00
CLSK balance_sheet (annual, 2025-09-30) — Total Debt: 824437000.00
CLSK balance_sheet (quarterly, 2025-09-30) — Total Debt: 824437000.00
CLSK balance_sheet (annual, 2025-09-30) — Total Equity Gross Minority Interest: 2175127000.00
CLSK balance_sheet (quarterly, 2025-09-30) — Total Equity Gross Minority Interest: 2175127000.00
CLSK income_statement (annual, 2025-09-30) — Total Expenses: 873347000.00
CLSK income_statement (quarterly, 2025-09-30) — Total Expenses: 286745000.00
CLSK balance_sheet (annual, 2025-09-30) — Total Liabilities Net Minority Interest: 1008504000.00
CLSK balance_sheet (quarterly, 2025-09-30) — Total Liabilities Net Minority Interest: 1008504000.00
CLSK balance_sheet (annual, 2025-09-30) — Total Non Current Assets: 1863590000.00
CLSK balance_sheet (quarterly, 2025-09-30) — Total Non Current Assets: 1863590000.00
CLSK balance_sheet (annual, 2025-09-30) — Total Non Current Liabilities Net Minority Interest: 692739000.00
CLSK balance_sheet (quarterly, 2025-09-30) — Total Non Current Liabilities Net Minority Interest: 692739000.00
CLSK income_statement (annual, 2025-09-30) — Total Operating Income As Reported: 318949000.00
CLSK income_statement (quarterly, 2025-09-30) — Total Operating Income As Reported: 834000.00
CLSK income_statement (annual, 2025-09-30) — Total Unusual Items: -1210000.00
CLSK income_statement (quarterly, 2025-09-30) — Total Unusual Items: -2526000.00
CLSK income_statement (annual, 2025-09-30) — Total Unusual Items Excluding Goodwill: -1210000.00
CLSK income_statement (quarterly, 2025-09-30) — Total Unusual Items Excluding Goodwill: -2526000.00
CLSK balance_sheet (annual, 2025-09-30) — Treasury Shares Number: 11759935.00
CLSK balance_sheet (quarterly, 2025-09-30) — Treasury Shares Number: 11759935.00
CLSK balance_sheet (annual, 2025-09-30) — Treasury Stock: 145000000.00
CLSK balance_sheet (quarterly, 2025-09-30) — Treasury Stock: 145000000.00
CLSK cash_flow (annual, 2025-09-30) — Unrealized Gain Loss On Investment Securities: -425646000.00
CLSK balance_sheet (annual, 2025-09-30) — Working Capital: 1004276000.00
CLSK balance_sheet (quarterly, 2025-09-30) — Working Capital: 1004276000.00
CLSK income_statement (annual, 2025-09-30) — Write Off: 0.00
CLSK income_statement (quarterly, 2025-09-30) — Write Off: 0.00
CLSK income_statement (quarterly, 2025-12-31) — +Operating Expense: 130321000.00
CLSK income_statement (quarterly, 2025-12-31) — +Total Revenue: 181180000.00
CLSK balance_sheet (quarterly, 2025-12-31) — Accounts Payable: 22116000.00
CLSK balance_sheet (quarterly, 2025-12-31) — Accumulated Depreciation: -639440000.00
CLSK balance_sheet (quarterly, 2025-12-31) — Additional Paid In Capital: 2494831000.00
CLSK cash_flow (quarterly, 2025-12-31) — Amortization Cash Flow: 942000.00
CLSK cash_flow (quarterly, 2025-12-31) — Amortization Of Intangibles: 942000.00
CLSK cash_flow (quarterly, 2025-12-31) — Asset Impairment Charge: 1398000.00
CLSK income_statement (quarterly, 2025-12-31) — Basic Average Shares: 281474949.00
CLSK income_statement (quarterly, 2025-12-31) — Basic EPS: -1.35
CLSK cash_flow (quarterly, 2025-12-31) — Beginning Cash Position: 46456000.00
CLSK balance_sheet (quarterly, 2025-12-31) — Buildings And Improvements: 96872000.00
CLSK cash_flow (quarterly, 2025-12-31) — Capital Expenditure: -36928000.00
CLSK balance_sheet (quarterly, 2025-12-31) — Capital Stock: 300000.00
CLSK balance_sheet (quarterly, 2025-12-31) — Cash And Cash Equivalents: 458097000.00
CLSK balance_sheet (quarterly, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 1288170000.00
CLSK cash_flow (quarterly, 2025-12-31) — Cash Dividends Paid: -396000.00
CLSK cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Financing Activities: 496378000.00
CLSK cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Investing Activities: 79590000.00
CLSK cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Operating Activities: -161135000.00
CLSK cash_flow (quarterly, 2025-12-31) — Change In Other Current Assets: -15211000.00
CLSK cash_flow (quarterly, 2025-12-31) — Change In Other Current Liabilities: -425000.00
CLSK cash_flow (quarterly, 2025-12-31) — Change In Payables And Accrued Expense: -16547000.00
CLSK cash_flow (quarterly, 2025-12-31) — Change In Prepaid Assets: 1278000.00
CLSK cash_flow (quarterly, 2025-12-31) — Change In Working Capital: -30905000.00
CLSK cash_flow (quarterly, 2025-12-31) — Changes In Cash: 414833000.00
CLSK balance_sheet (quarterly, 2025-12-31) — Common Stock: 298000.00
CLSK balance_sheet (quarterly, 2025-12-31) — Common Stock Equity: 1382254000.00
CLSK cash_flow (quarterly, 2025-12-31) — Common Stock Issuance: 0.00
CLSK cash_flow (quarterly, 2025-12-31) — Common Stock Payments: -460000000.00
CLSK balance_sheet (quarterly, 2025-12-31) — Construction In Progress: 162167000.00
CLSK income_statement (quarterly, 2025-12-31) — Cost Of Revenue: 119406000.00
CLSK balance_sheet (quarterly, 2025-12-31) — Current Accrued Expenses: 103689000.00
CLSK balance_sheet (quarterly, 2025-12-31) — Current Assets: 1470646000.00
CLSK balance_sheet (quarterly, 2025-12-31) — Current Debt: 2532000.00
CLSK balance_sheet (quarterly, 2025-12-31) — Current Debt And Capital Lease Obligation: 2532000.00
CLSK balance_sheet (quarterly, 2025-12-31) — Current Liabilities: 139497000.00
CLSK cash_flow (quarterly, 2025-12-31) — Deferred Income Tax: -31415000.00
CLSK cash_flow (quarterly, 2025-12-31) — Deferred Tax: -31415000.00
CLSK cash_flow (quarterly, 2025-12-31) — Depreciation: 105368000.00
CLSK cash_flow (quarterly, 2025-12-31) — Depreciation Amortization Depletion: 106311000.00
CLSK income_statement (quarterly, 2025-12-31) — Depreciation Amortization Depletion Income Statement: 106311000.00
CLSK cash_flow (quarterly, 2025-12-31) — Depreciation And Amortization: 106311000.00
CLSK income_statement (quarterly, 2025-12-31) — Depreciation And Amortization In Income Statement: 106311000.00
CLSK income_statement (quarterly, 2025-12-31) — Diluted Average Shares: 281474949.00
CLSK income_statement (quarterly, 2025-12-31) — Diluted EPS: -1.35
CLSK income_statement (quarterly, 2025-12-31) — Diluted NI Availto Com Stockholders: -378711000.00
CLSK balance_sheet (quarterly, 2025-12-31) — Dividends Payable: 0.00
CLSK income_statement (quarterly, 2025-12-31) — EBIT: -406430000.00
CLSK income_statement (quarterly, 2025-12-31) — EBITDA: -300119000.00
CLSK cash_flow (quarterly, 2025-12-31) — End Cash Position: 461289000.00
CLSK cash_flow (quarterly, 2025-12-31) — Financing Cash Flow: 496378000.00
CLSK cash_flow (quarterly, 2025-12-31) — Free Cash Flow: -198063000.00
CLSK cash_flow (quarterly, 2025-12-31) — Gain Loss On Investment Securities: -11795000.00
CLSK income_statement (quarterly, 2025-12-31) — Gain On Sale Of Ppe: 223000.00
CLSK income_statement (quarterly, 2025-12-31) — Gain On Sale Of Security: -235037000.00
CLSK income_statement (quarterly, 2025-12-31) — General And Administrative Expense: 20848000.00
CLSK balance_sheet (quarterly, 2025-12-31) — Goodwill: 131658000.00
CLSK balance_sheet (quarterly, 2025-12-31) — Goodwill And Other Intangible Assets: 136565000.00
CLSK balance_sheet (quarterly, 2025-12-31) — Gross PPE: 2131883000.00
CLSK income_statement (quarterly, 2025-12-31) — Gross Profit: 61774000.00
CLSK balance_sheet (quarterly, 2025-12-31) — Hedging Assets Current: 0.00
CLSK income_statement (quarterly, 2025-12-31) — Impairment Of Capital Assets: 1398000.00
CLSK income_statement (quarterly, 2025-12-31) — Interest Expense: 3696000.00
CLSK income_statement (quarterly, 2025-12-31) — Interest Expense Non Operating: 3696000.00
CLSK income_statement (quarterly, 2025-12-31) — Interest Income: 2185000.00
CLSK income_statement (quarterly, 2025-12-31) — Interest Income Non Operating: 2185000.00
CLSK cash_flow (quarterly, 2025-12-31) — Interest Paid Supplemental Data: 2396000.00
CLSK balance_sheet (quarterly, 2025-12-31) — Invested Capital: 3171545000.00
CLSK cash_flow (quarterly, 2025-12-31) — Investing Cash Flow: 79590000.00
CLSK balance_sheet (quarterly, 2025-12-31) — Investmentin Financial Assets: 171924000.00
CLSK balance_sheet (quarterly, 2025-12-31) — Investments And Advances: 171924000.00
CLSK cash_flow (quarterly, 2025-12-31) — Issuance Of Capital Stock: 0.00
CLSK cash_flow (quarterly, 2025-12-31) — Issuance Of Debt: 1209086000.00
CLSK balance_sheet (quarterly, 2025-12-31) — Land And Improvements: 109081000.00
CLSK balance_sheet (quarterly, 2025-12-31) — Leases: 2941000.00
CLSK balance_sheet (quarterly, 2025-12-31) — Long Term Debt: 1786759000.00
CLSK balance_sheet (quarterly, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 1786759000.00
CLSK cash_flow (quarterly, 2025-12-31) — Long Term Debt Issuance: 1209086000.00
CLSK cash_flow (quarterly, 2025-12-31) — Long Term Debt Payments: -251131000.00
CLSK balance_sheet (quarterly, 2025-12-31) — Machinery Furniture Equipment: 22728000.00
CLSK cash_flow (quarterly, 2025-12-31) — Net Business Purchase And Sale: -21607000.00
CLSK cash_flow (quarterly, 2025-12-31) — Net Common Stock Issuance: -460000000.00
CLSK balance_sheet (quarterly, 2025-12-31) — Net Debt: 1331194000.00
CLSK income_statement (quarterly, 2025-12-31) — Net Income: -378711000.00
CLSK income_statement (quarterly, 2025-12-31) — Net Income Common Stockholders: -378711000.00
CLSK income_statement (quarterly, 2025-12-31) — Net Income Continuous Operations: -378711000.00
CLSK income_statement (quarterly, 2025-12-31) — Net Income From Continuing And Discontinued Operation: -378711000.00
CLSK income_statement (quarterly, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: -378711000.00
CLSK cash_flow (quarterly, 2025-12-31) — Net Income From Continuing Operations: -378711000.00
CLSK income_statement (quarterly, 2025-12-31) — Net Income Including Noncontrolling Interests: -378711000.00
CLSK income_statement (quarterly, 2025-12-31) — Net Interest Income: -1511000.00
CLSK cash_flow (quarterly, 2025-12-31) — Net Investment Purchase And Sale: 188528000.00
CLSK cash_flow (quarterly, 2025-12-31) — Net Issuance Payments Of Debt: 957955000.00
CLSK cash_flow (quarterly, 2025-12-31) — Net Long Term Debt Issuance: 957955000.00
CLSK income_statement (quarterly, 2025-12-31) — Net Non Operating Interest Income Expense: -1511000.00
CLSK cash_flow (quarterly, 2025-12-31) — Net Other Financing Charges: -2113000.00
CLSK cash_flow (quarterly, 2025-12-31) — Net Other Investing Changes: -50403000.00
CLSK balance_sheet (quarterly, 2025-12-31) — Net PPE: 1492443000.00
CLSK cash_flow (quarterly, 2025-12-31) — Net PPE Purchase And Sale: -36928000.00
CLSK balance_sheet (quarterly, 2025-12-31) — Net Tangible Assets: 1245691000.00
CLSK balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Liabilities: 13457000.00
CLSK balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Taxes Liabilities: 13457000.00
CLSK income_statement (quarterly, 2025-12-31) — Normalized EBITDA: -63907000.00
CLSK income_statement (quarterly, 2025-12-31) — Normalized Income: -160687324.00
CLSK cash_flow (quarterly, 2025-12-31) — Operating Cash Flow: -161135000.00
CLSK cash_flow (quarterly, 2025-12-31) — Operating Gains Losses: -12018000.00
CLSK income_statement (quarterly, 2025-12-31) — Operating Income: -68547000.00
CLSK income_statement (quarterly, 2025-12-31) — Operating Revenue: 181180000.00
CLSK balance_sheet (quarterly, 2025-12-31) — Ordinary Shares Number: 255749498.00
CLSK balance_sheet (quarterly, 2025-12-31) — Other Current Assets: 35121000.00
CLSK balance_sheet (quarterly, 2025-12-31) — Other Current Liabilities: 11160000.00
CLSK income_statement (quarterly, 2025-12-31) — Other Gand A: 20848000.00
CLSK income_statement (quarterly, 2025-12-31) — Other Income Expense: -340068000.00
CLSK balance_sheet (quarterly, 2025-12-31) — Other Intangible Assets: 4907000.00
CLSK cash_flow (quarterly, 2025-12-31) — Other Non Cash Items: -178379000.00
CLSK balance_sheet (quarterly, 2025-12-31) — Other Non Current Assets: 54601000.00
CLSK balance_sheet (quarterly, 2025-12-31) — Other Non Current Liabilities: 4210000.00
CLSK income_statement (quarterly, 2025-12-31) — Other Non Operating Income Expenses: -103856000.00
CLSK balance_sheet (quarterly, 2025-12-31) — Other Properties: 322717000.00
CLSK balance_sheet (quarterly, 2025-12-31) — Other Receivables: 144163000.00
CLSK balance_sheet (quarterly, 2025-12-31) — Other Short Term Investments: 830073000.00
CLSK income_statement (quarterly, 2025-12-31) — Other Taxes: 3162000.00
CLSK balance_sheet (quarterly, 2025-12-31) — Payables: 22116000.00
CLSK balance_sheet (quarterly, 2025-12-31) — Payables And Accrued Expenses: 125805000.00
CLSK balance_sheet (quarterly, 2025-12-31) — Preferred Shares Number: 1750000.00
CLSK balance_sheet (quarterly, 2025-12-31) — Preferred Stock: 2000.00
CLSK cash_flow (quarterly, 2025-12-31) — Preferred Stock Dividend Paid: -396000.00
CLSK balance_sheet (quarterly, 2025-12-31) — Preferred Stock Equity: 2000.00
CLSK income_statement (quarterly, 2025-12-31) — Pretax Income: -410126000.00
CLSK cash_flow (quarterly, 2025-12-31) — Proceeds From Stock Option Exercised: 932000.00
CLSK balance_sheet (quarterly, 2025-12-31) — Properties: 1415377000.00
CLSK cash_flow (quarterly, 2025-12-31) — Purchase Of Business: -21607000.00
CLSK cash_flow (quarterly, 2025-12-31) — Purchase Of Investment: -872000.00
CLSK cash_flow (quarterly, 2025-12-31) — Purchase Of PPE: -36928000.00
CLSK balance_sheet (quarterly, 2025-12-31) — Receivables: 144163000.00
CLSK income_statement (quarterly, 2025-12-31) — Reconciled Cost Of Revenue: 119406000.00
CLSK income_statement (quarterly, 2025-12-31) — Reconciled Depreciation: 106311000.00
CLSK cash_flow (quarterly, 2025-12-31) — Repayment Of Debt: -251131000.00
CLSK cash_flow (quarterly, 2025-12-31) — Repurchase Of Capital Stock: -460000000.00
CLSK balance_sheet (quarterly, 2025-12-31) — Restricted Cash: 3192000.00
CLSK balance_sheet (quarterly, 2025-12-31) — Retained Earnings: -504605000.00
CLSK cash_flow (quarterly, 2025-12-31) — Sale Of Investment: 189400000.00
CLSK cash_flow (quarterly, 2025-12-31) — Sale Of PPE: 0.00
CLSK income_statement (quarterly, 2025-12-31) — Selling General And Administration: 20848000.00
CLSK balance_sheet (quarterly, 2025-12-31) — Share Issued: 298114889.00
CLSK income_statement (quarterly, 2025-12-31) — Special Income Charges: -1175000.00
CLSK cash_flow (quarterly, 2025-12-31) — Stock Based Compensation: 12132000.00
CLSK balance_sheet (quarterly, 2025-12-31) — Stockholders Equity: 1382256000.00
CLSK balance_sheet (quarterly, 2025-12-31) — Tangible Book Value: 1245689000.00
CLSK income_statement (quarterly, 2025-12-31) — Tax Effect Of Unusual Items: -18188324.00
CLSK income_statement (quarterly, 2025-12-31) — Tax Provision: -31415000.00
CLSK income_statement (quarterly, 2025-12-31) — Tax Rate For Calcs: 0.08
CLSK balance_sheet (quarterly, 2025-12-31) — Total Assets: 3326179000.00
CLSK balance_sheet (quarterly, 2025-12-31) — Total Capitalization: 3169015000.00
CLSK balance_sheet (quarterly, 2025-12-31) — Total Debt: 1789291000.00
CLSK balance_sheet (quarterly, 2025-12-31) — Total Equity Gross Minority Interest: 1382256000.00
CLSK income_statement (quarterly, 2025-12-31) — Total Expenses: 249727000.00
CLSK balance_sheet (quarterly, 2025-12-31) — Total Liabilities Net Minority Interest: 1943923000.00
CLSK balance_sheet (quarterly, 2025-12-31) — Total Non Current Assets: 1855533000.00
CLSK balance_sheet (quarterly, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 1804426000.00
CLSK income_statement (quarterly, 2025-12-31) — Total Operating Income As Reported: -316554000.00
CLSK income_statement (quarterly, 2025-12-31) — Total Unusual Items: -236212000.00
CLSK income_statement (quarterly, 2025-12-31) — Total Unusual Items Excluding Goodwill: -236212000.00
CLSK balance_sheet (quarterly, 2025-12-31) — Treasury Shares Number: 42365391.00
CLSK balance_sheet (quarterly, 2025-12-31) — Treasury Stock: 608270000.00
CLSK cash_flow (quarterly, 2025-12-31) — Unrealized Gain Loss On Investment Securities: 350452000.00
CLSK balance_sheet (quarterly, 2025-12-31) — Working Capital: 1331149000.00
CLSK income_statement (quarterly, 2026-03-31) — +Operating Expense: 143369000.00
CLSK income_statement (quarterly, 2026-03-31) — +Total Revenue: 136408000.00
CLSK balance_sheet (quarterly, 2026-03-31) — Accounts Payable: 18058000.00
CLSK balance_sheet (quarterly, 2026-03-31) — Accumulated Depreciation: -746466000.00
CLSK balance_sheet (quarterly, 2026-03-31) — Additional Paid In Capital: 2506997000.00
CLSK cash_flow (quarterly, 2026-03-31) — Amortization Cash Flow: 617000.00
CLSK cash_flow (quarterly, 2026-03-31) — Amortization Of Intangibles: 617000.00
CLSK cash_flow (quarterly, 2026-03-31) — Asset Impairment Charge: 4008000.00
CLSK income_statement (quarterly, 2026-03-31) — Average Dilution Earnings: 0.00
CLSK income_statement (quarterly, 2026-03-31) — Basic Average Shares: 267827913.00
CLSK income_statement (quarterly, 2026-03-31) — Basic EPS: -1.52
CLSK cash_flow (quarterly, 2026-03-31) — Beginning Cash Position: 461289000.00
CLSK balance_sheet (quarterly, 2026-03-31) — Buildings And Improvements: 100633000.00
CLSK cash_flow (quarterly, 2026-03-31) — Capital Expenditure: -37594000.00
CLSK balance_sheet (quarterly, 2026-03-31) — Capital Stock: 301000.00
CLSK balance_sheet (quarterly, 2026-03-31) — Cash And Cash Equivalents: 260287000.00
CLSK balance_sheet (quarterly, 2026-03-31) — Cash Cash Equivalents And Short Term Investments: 934734000.00
CLSK cash_flow (quarterly, 2026-03-31) — Cash Dividends Paid: -30000000.00
CLSK cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Financing Activities: -31367000.00
CLSK cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Investing Activities: -30595000.00
CLSK cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Operating Activities: -135827000.00
CLSK cash_flow (quarterly, 2026-03-31) — Change In Other Current Liabilities: -456000.00
CLSK cash_flow (quarterly, 2026-03-31) — Change In Payables And Accrued Expense: -8274000.00
CLSK cash_flow (quarterly, 2026-03-31) — Change In Prepaid Assets: 2646000.00
CLSK cash_flow (quarterly, 2026-03-31) — Change In Working Capital: 9127000.00
CLSK cash_flow (quarterly, 2026-03-31) — Changes In Cash: -197789000.00
CLSK balance_sheet (quarterly, 2026-03-31) — Common Stock: 299000.00
CLSK balance_sheet (quarterly, 2026-03-31) — Common Stock Equity: 986158000.00
CLSK cash_flow (quarterly, 2026-03-31) — Common Stock Issuance: 0.00
CLSK cash_flow (quarterly, 2026-03-31) — Common Stock Payments: 0.00
CLSK balance_sheet (quarterly, 2026-03-31) — Construction In Progress: 181424000.00
CLSK income_statement (quarterly, 2026-03-31) — Cost Of Revenue: 106613000.00
CLSK balance_sheet (quarterly, 2026-03-31) — Current Accrued Expenses: 30552000.00
CLSK balance_sheet (quarterly, 2026-03-31) — Current Assets: 1099037000.00
CLSK balance_sheet (quarterly, 2026-03-31) — Current Debt: 2485000.00
CLSK balance_sheet (quarterly, 2026-03-31) — Current Debt And Capital Lease Obligation: 2485000.00
CLSK balance_sheet (quarterly, 2026-03-31) — Current Liabilities: 133068000.00
CLSK cash_flow (quarterly, 2026-03-31) — Deferred Income Tax: -9891000.00
CLSK cash_flow (quarterly, 2026-03-31) — Deferred Tax: -9891000.00
CLSK cash_flow (quarterly, 2026-03-31) — Depreciation: 115265000.00
CLSK cash_flow (quarterly, 2026-03-31) — Depreciation Amortization Depletion: 115881000.00
CLSK income_statement (quarterly, 2026-03-31) — Depreciation Amortization Depletion Income Statement: 115881000.00
CLSK cash_flow (quarterly, 2026-03-31) — Depreciation And Amortization: 115881000.00
CLSK income_statement (quarterly, 2026-03-31) — Depreciation And Amortization In Income Statement: 115881000.00
CLSK income_statement (quarterly, 2026-03-31) — Diluted Average Shares: 267827913.00
CLSK income_statement (quarterly, 2026-03-31) — Diluted EPS: -1.52
CLSK income_statement (quarterly, 2026-03-31) — Diluted NI Availto Com Stockholders: -408343000.00
CLSK balance_sheet (quarterly, 2026-03-31) — Dividends Payable: 0.00
CLSK income_statement (quarterly, 2026-03-31) — EBIT: -386180000.00
CLSK income_statement (quarterly, 2026-03-31) — EBITDA: -270299000.00
CLSK cash_flow (quarterly, 2026-03-31) — End Cash Position: 263500000.00
CLSK cash_flow (quarterly, 2026-03-31) — Financing Cash Flow: -31367000.00
CLSK cash_flow (quarterly, 2026-03-31) — Free Cash Flow: -173421000.00
CLSK cash_flow (quarterly, 2026-03-31) — Gain Loss On Investment Securities: 4840000.00
CLSK income_statement (quarterly, 2026-03-31) — Gain On Sale Of Ppe: -3990000.00
CLSK income_statement (quarterly, 2026-03-31) — Gain On Sale Of Security: -4840000.00
CLSK income_statement (quarterly, 2026-03-31) — General And Administrative Expense: 25757000.00
CLSK balance_sheet (quarterly, 2026-03-31) — Goodwill: 131658000.00
CLSK balance_sheet (quarterly, 2026-03-31) — Goodwill And Other Intangible Assets: 135949000.00
CLSK balance_sheet (quarterly, 2026-03-31) — Gross PPE: 2222823000.00
CLSK income_statement (quarterly, 2026-03-31) — Gross Profit: 29795000.00
CLSK balance_sheet (quarterly, 2026-03-31) — Hedging Assets Current: 1499000.00
CLSK income_statement (quarterly, 2026-03-31) — Impairment Of Capital Assets: 0.00
CLSK income_statement (quarterly, 2026-03-31) — Interest Expense: 2054000.00
CLSK income_statement (quarterly, 2026-03-31) — Interest Expense Non Operating: 2054000.00
CLSK income_statement (quarterly, 2026-03-31) — Interest Income: 3072000.00
CLSK income_statement (quarterly, 2026-03-31) — Interest Income Non Operating: 3072000.00
CLSK cash_flow (quarterly, 2026-03-31) — Interest Paid Supplemental Data: 352000.00
CLSK balance_sheet (quarterly, 2026-03-31) — Invested Capital: 2776839000.00
CLSK cash_flow (quarterly, 2026-03-31) — Investing Cash Flow: -30595000.00
CLSK balance_sheet (quarterly, 2026-03-31) — Investmentin Financial Assets: 138774000.00
CLSK balance_sheet (quarterly, 2026-03-31) — Investments And Advances: 138774000.00
CLSK cash_flow (quarterly, 2026-03-31) — Issuance Of Capital Stock: 0.00
CLSK cash_flow (quarterly, 2026-03-31) — Issuance Of Debt: 0.00
CLSK balance_sheet (quarterly, 2026-03-31) — Land And Improvements: 138231000.00
CLSK balance_sheet (quarterly, 2026-03-31) — Leases: 2941000.00
CLSK balance_sheet (quarterly, 2026-03-31) — Long Term Debt: 1788196000.00
CLSK balance_sheet (quarterly, 2026-03-31) — Long Term Debt And Capital Lease Obligation: 1788196000.00
CLSK cash_flow (quarterly, 2026-03-31) — Long Term Debt Issuance: 0.00
CLSK cash_flow (quarterly, 2026-03-31) — Long Term Debt Payments: -669000.00
CLSK balance_sheet (quarterly, 2026-03-31) — Machinery Furniture Equipment: 24661000.00
CLSK cash_flow (quarterly, 2026-03-31) — Net Business Purchase And Sale: 11675000.00
CLSK cash_flow (quarterly, 2026-03-31) — Net Common Stock Issuance: 0.00
CLSK balance_sheet (quarterly, 2026-03-31) — Net Debt: 1530394000.00
CLSK income_statement (quarterly, 2026-03-31) — Net Income: -378343000.00
CLSK income_statement (quarterly, 2026-03-31) — Net Income Common Stockholders: -408343000.00
CLSK income_statement (quarterly, 2026-03-31) — Net Income Continuous Operations: -378343000.00
CLSK income_statement (quarterly, 2026-03-31) — Net Income From Continuing And Discontinued Operation: -378343000.00
CLSK income_statement (quarterly, 2026-03-31) — Net Income From Continuing Operation Net Minority Interest: -378343000.00
CLSK cash_flow (quarterly, 2026-03-31) — Net Income From Continuing Operations: -378343000.00
CLSK income_statement (quarterly, 2026-03-31) — Net Income Including Noncontrolling Interests: -378343000.00
CLSK income_statement (quarterly, 2026-03-31) — Net Interest Income: 1018000.00
CLSK cash_flow (quarterly, 2026-03-31) — Net Investment Purchase And Sale: 8570000.00
CLSK cash_flow (quarterly, 2026-03-31) — Net Issuance Payments Of Debt: -669000.00
CLSK cash_flow (quarterly, 2026-03-31) — Net Long Term Debt Issuance: -669000.00
CLSK income_statement (quarterly, 2026-03-31) — Net Non Operating Interest Income Expense: 1018000.00
CLSK cash_flow (quarterly, 2026-03-31) — Net Other Financing Charges: -812000.00
CLSK cash_flow (quarterly, 2026-03-31) — Net Other Investing Changes: -13246000.00
CLSK balance_sheet (quarterly, 2026-03-31) — Net PPE: 1476357000.00
CLSK cash_flow (quarterly, 2026-03-31) — Net PPE Purchase And Sale: -37594000.00
CLSK balance_sheet (quarterly, 2026-03-31) — Net Tangible Assets: 850211000.00
CLSK balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Liabilities: 3566000.00
CLSK balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Taxes Liabilities: 3566000.00
CLSK income_statement (quarterly, 2026-03-31) — Normalized EBITDA: -257461000.00
CLSK income_statement (quarterly, 2026-03-31) — Normalized Income: -365825950.00
CLSK cash_flow (quarterly, 2026-03-31) — Operating Cash Flow: -135827000.00
CLSK cash_flow (quarterly, 2026-03-31) — Operating Gains Losses: 8830000.00
CLSK income_statement (quarterly, 2026-03-31) — Operating Income: -113574000.00
CLSK income_statement (quarterly, 2026-03-31) — Operating Revenue: 136408000.00
CLSK balance_sheet (quarterly, 2026-03-31) — Ordinary Shares Number: 256599199.00
CLSK balance_sheet (quarterly, 2026-03-31) — Other Current Assets: 47651000.00
CLSK balance_sheet (quarterly, 2026-03-31) — Other Current Liabilities: 10994000.00
CLSK income_statement (quarterly, 2026-03-31) — Other Gand A: 25757000.00
CLSK income_statement (quarterly, 2026-03-31) — Other Income Expense: -275678000.00
CLSK balance_sheet (quarterly, 2026-03-31) — Other Intangible Assets: 4291000.00
CLSK cash_flow (quarterly, 2026-03-31) — Other Non Cash Items: -160438000.00
CLSK balance_sheet (quarterly, 2026-03-31) — Other Non Current Assets: 63384000.00
CLSK balance_sheet (quarterly, 2026-03-31) — Other Non Current Liabilities: 2511000.00
CLSK income_statement (quarterly, 2026-03-31) — Other Non Operating Income Expenses: -262840000.00
CLSK balance_sheet (quarterly, 2026-03-31) — Other Properties: 345124000.00
CLSK balance_sheet (quarterly, 2026-03-31) — Other Receivables: 111940000.00
CLSK balance_sheet (quarterly, 2026-03-31) — Other Short Term Investments: 674447000.00
CLSK income_statement (quarterly, 2026-03-31) — Other Taxes: 1731000.00
CLSK balance_sheet (quarterly, 2026-03-31) — Payables: 89037000.00
CLSK balance_sheet (quarterly, 2026-03-31) — Payables And Accrued Expenses: 119589000.00
CLSK balance_sheet (quarterly, 2026-03-31) — Preferred Shares Number: 1750000.00
CLSK balance_sheet (quarterly, 2026-03-31) — Preferred Stock: 2000.00
CLSK cash_flow (quarterly, 2026-03-31) — Preferred Stock Dividend Paid: -30000000.00
CLSK income_statement (quarterly, 2026-03-31) — Preferred Stock Dividends: 30000000.00
CLSK balance_sheet (quarterly, 2026-03-31) — Preferred Stock Equity: 2000.00
CLSK income_statement (quarterly, 2026-03-31) — Pretax Income: -388234000.00
CLSK cash_flow (quarterly, 2026-03-31) — Proceeds From Stock Option Exercised: 114000.00
CLSK balance_sheet (quarterly, 2026-03-31) — Properties: 1429809000.00
CLSK cash_flow (quarterly, 2026-03-31) — Purchase Of Business: 8314000.00
CLSK cash_flow (quarterly, 2026-03-31) — Purchase Of Investment: -178797000.00
CLSK cash_flow (quarterly, 2026-03-31) — Purchase Of PPE: -37594000.00
CLSK balance_sheet (quarterly, 2026-03-31) — Receivables: 111940000.00
CLSK income_statement (quarterly, 2026-03-31) — Reconciled Cost Of Revenue: 106613000.00
CLSK income_statement (quarterly, 2026-03-31) — Reconciled Depreciation: 115881000.00
CLSK cash_flow (quarterly, 2026-03-31) — Repayment Of Debt: -669000.00
CLSK cash_flow (quarterly, 2026-03-31) — Repurchase Of Capital Stock: 0.00
CLSK balance_sheet (quarterly, 2026-03-31) — Restricted Cash: 3213000.00
CLSK balance_sheet (quarterly, 2026-03-31) — Retained Earnings: -912948000.00
CLSK cash_flow (quarterly, 2026-03-31) — Sale Of Investment: 187367000.00
CLSK income_statement (quarterly, 2026-03-31) — Selling General And Administration: 25757000.00
CLSK balance_sheet (quarterly, 2026-03-31) — Share Issued: 298964590.00
CLSK income_statement (quarterly, 2026-03-31) — Special Income Charges: -7998000.00
CLSK cash_flow (quarterly, 2026-03-31) — Stock Based Compensation: 12054000.00
CLSK balance_sheet (quarterly, 2026-03-31) — Stockholders Equity: 986160000.00
CLSK balance_sheet (quarterly, 2026-03-31) — Tangible Book Value: 850209000.00
CLSK income_statement (quarterly, 2026-03-31) — Tax Effect Of Unusual Items: -320950.00
CLSK income_statement (quarterly, 2026-03-31) — Tax Provision: -9891000.00
CLSK income_statement (quarterly, 2026-03-31) — Tax Rate For Calcs: 0.03
CLSK balance_sheet (quarterly, 2026-03-31) — Total Assets: 2913501000.00
CLSK balance_sheet (quarterly, 2026-03-31) — Total Capitalization: 2774356000.00
CLSK balance_sheet (quarterly, 2026-03-31) — Total Debt: 1790681000.00
CLSK balance_sheet (quarterly, 2026-03-31) — Total Equity Gross Minority Interest: 986160000.00
CLSK income_statement (quarterly, 2026-03-31) — Total Expenses: 249982000.00
CLSK balance_sheet (quarterly, 2026-03-31) — Total Liabilities Net Minority Interest: 1927341000.00
CLSK balance_sheet (quarterly, 2026-03-31) — Total Non Current Assets: 1814464000.00
CLSK balance_sheet (quarterly, 2026-03-31) — Total Non Current Liabilities Net Minority Interest: 1794273000.00
CLSK income_statement (quarterly, 2026-03-31) — Total Operating Income As Reported: -345679000.00
CLSK balance_sheet (quarterly, 2026-03-31) — Total Tax Payable: 70979000.00
CLSK income_statement (quarterly, 2026-03-31) — Total Unusual Items: -12838000.00
CLSK income_statement (quarterly, 2026-03-31) — Total Unusual Items Excluding Goodwill: -12838000.00
CLSK balance_sheet (quarterly, 2026-03-31) — Treasury Shares Number: 42365391.00
CLSK balance_sheet (quarterly, 2026-03-31) — Treasury Stock: 608190000.00
CLSK cash_flow (quarterly, 2026-03-31) — Unrealized Gain Loss On Investment Securities: 262945000.00
CLSK balance_sheet (quarterly, 2026-03-31) — Working Capital: 965969000.00
CLSK income_statement (quarterly, 2026-03-31) — Write Off: 4008000.00
CLST cash_flow (annual, 2021-12-31) — Common Stock Issuance: 50835000.00
CLST balance_sheet (annual, 2021-12-31) — Construction In Progress: 13000.00
CLST income_statement (annual, 2021-12-31) — Insurance And Claims: 63000.00
CLST cash_flow (annual, 2021-12-31) — Issuance Of Capital Stock: 50835000.00
CLST cash_flow (annual, 2021-12-31) — Long Term Debt Payments: 0.00
CLST income_statement (annual, 2021-12-31) — Other Gand A: 115000.00
CLST income_statement (annual, 2021-12-31) — Other Special Charges: -25000.00
CLST cash_flow (annual, 2021-12-31) — Proceeds From Stock Option Exercised: -4232000.00
CLST cash_flow (annual, 2021-12-31) — Repayment Of Debt: 0.00
CLST income_statement (annual, 2022-12-31) — +Total Revenue: 8336000.00
CLST balance_sheet (annual, 2022-12-31) — Accounts Receivable: 673000.00
CLST balance_sheet (annual, 2022-12-31) — Accumulated Depreciation: -3415000.00
CLST balance_sheet (annual, 2022-12-31) — Additional Paid In Capital: 51062000.00
CLST cash_flow (annual, 2022-12-31) — Amortization Of Securities: 461000.00
CLST cash_flow (annual, 2022-12-31) — Asset Impairment Charge: -8000.00
CLST income_statement (annual, 2022-12-31) — Basic Average Shares: 4500000.00
CLST income_statement (annual, 2022-12-31) — Basic EPS: 0.04
CLST cash_flow (annual, 2022-12-31) — Beginning Cash Position: 40884000.00
CLST balance_sheet (annual, 2022-12-31) — Buildings And Improvements: 6116000.00
CLST cash_flow (annual, 2022-12-31) — Capital Expenditure: -252000.00
CLST balance_sheet (annual, 2022-12-31) — Capital Stock: 53000.00
CLST balance_sheet (annual, 2022-12-31) — Cash And Cash Equivalents: 13472000.00
CLST balance_sheet (annual, 2022-12-31) — Cash Cash Equivalents And Federal Funds Sold: 13472000.00
CLST balance_sheet (annual, 2022-12-31) — Cash Financial: 13472000.00
CLST cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Financing Activities: -14041000.00
CLST cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Investing Activities: -14143000.00
CLST cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Operating Activities: 772000.00
CLST cash_flow (annual, 2022-12-31) — Change In Other Current Assets: -23000.00
CLST cash_flow (annual, 2022-12-31) — Change In Other Current Liabilities: -302000.00